Trial intelligence / Profile preview

Cellcept in Lupus Arthritis

NCT00594932Phase 2Completed

Sponsor
Oklahoma Medical Research Foundation
Start
Nov 2006
Primary completion
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of mycophenolate mofetil in systemic lupus erythematosus (SLE), arthritis, sponsored by Oklahoma Medical Research Foundation. Started Nov 2006; status: completed.

02

Drugs

mycophenolate mofetil
03

Conditions

systemic lupus erythematosus (SLE)arthritis

Beyond the preview

Go deeper on NCT00594932.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00594932.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call